Evidence map›Paper›PMID 34821609›Full record

ArticleBehavioral sciences (Basel, Switzerland)2021

COVID-19 Vaccine Hesitancy and Emerging Variants: Evidence from Six Countries.

Sherry Mangla, Fatima Tuz Zohra Makkia, Ashok Kumar Pathak, Renee Robinson, Nargis Sultana, Kranthi Swaroop Koonisetty, Ajlina Karamehic-Muratovic, Uyen-Sa D T Nguyen, Alfonso J Rodriguez-Morales, Jorge A Sanchez-Duque and 4 more

Open access · goldAbstract read
In one paragraph

Article in Behavioral sciences (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 5 countries.

Sherry ManglaInternational Institute for Population Sciences, Mumbai 400088, Maharashtra, India.
Fatima Tuz Zohra MakkiaDepartment of Epidemiology, Human Genetics and Environmental Sciences, University of Texas Health Science Center, 1200 Pressler Street, Houston, TX 77030, USA.
Ashok Kumar PathakDepartment of Mathematics and Statistics, Central University of Punjab, Bathinda 151401, Punjab, India.ORCID 0000-0002-0774-1202
Renee RobinsonUniversity of Alaska Anchorage/Idaho State University College of Pharmacy, 2533 Providence Drive, PSB 108B, Anchorage, AK 99508, USA.ORCID 0000-0003-1807-0827
Nargis SultanaOffice of Public Health Studies, Thompson School of Social Work and Public Health, University of Hawai'i at Mānoa, Honolulu, HI 96822, USA.ORCID 0000-0003-0721-3482
Kranthi Swaroop KoonisettyDepartment of Biostatistics and Epidemiology, University of North Texas Health Science Center, Fort Worth, TX 76177, USA.
Ajlina Karamehic-MuratovicDepartment of Sociology and Anthropology, St. Louis University, St. Louis, MO 63108, USA.
Uyen-Sa D T NguyenDepartment of Biostatistics and Epidemiology, University of North Texas Health Science Center, Fort Worth, TX 76177, USA.
Alfonso J Rodriguez-MoralesGrupo de Investigación Biomedicina, Faculty of Medicine, Fundacion Universitaria Autonoma de las Américas, Pereira 660003, Colombia.
Jorge A Sanchez-DuqueGrupo de Investigación Salud, Familia y Sociedad, Department of Social Medicine and Family Health, Faculty of Health Sciences, Universidad del Cauca, Popayán 660003, Colombia.ORCID 0000-0002-8913-7729
Patrick T ZambaDepartment of Biostatistics and Epidemiology, University of North Texas Health Science Center, Fort Worth, TX 76177, USA.
Nasrin AghamohammadiCentre for Epidemiology and Evidence-Based Practice, Department of Social and Preventive Medicine, University of Malaya Kuala Lumpur, Kula Lumpur 50603, Malaysia.ORCID 0000-0002-7063-1671
Fong CsInstitute for Advanced Studies, University of Malaya, Kuala Lumpur 50603, Malaysia.ORCID 0000-0002-7068-2284
Ubydul HaqueDepartment of Biostatistics and Epidemiology, University of North Texas Health Science Center, Fort Worth, TX 76177, USA.ORCID 0000-0002-7413-1017
University of North Texas · USUniversity of Malaya · MYCentral University of Punjab · INIdaho State University · USInternational Institute for Population Sciences · INSaint Louis University · USThe University of Texas Health Science Center at Houston · USUniversidad Científica del Sur · PEUniversity of Cauca · COUniversity of Hawaiʻi at Mānoa · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As the world tries to cope with the devastating effects of the COVID-19 pandemic and emerging variants of the virus, COVID-19 vaccination has become an even more critical tool toward normalcy. The effectiveness of the vaccination program and specifically vaccine uptake and coverage, however, is a function of an individual's knowledge and individual opinion about the disease and available vaccines. This study investigated the knowledge, attitudes, and resulting community practice(s) associated with the new COVID-19 variants and vaccines in Bangladesh, Colombia, India, Malaysia, Zimbabwe, and the USA. A cross-sectional web-based Knowledge, Attitudes, and Practices (KAP) survey was administered to respondents living in six different countries using a structured and multi-item questionnaire. Survey questions were translated into English, Spanish, and Malay to accommodate the local language in each country. Associations between KAP and a range of explanatory variables were assessed using univariate and multiple logistic regression. A total of 781 responses were included in the final analysis. The Knowledge score mean was 24 (out of 46), Attitude score 28.9 (out of 55), and Practice score 7.3 (out of 11). Almost 65% of the respondents reported being knowledgeable about COVID-19 variants and vaccination, 55% reported a positive attitude toward available COVID-19 vaccines, and 85% reported engaging in practices that supported COVID-19 vaccination. From the multiple logistic models, we found post-graduate education (AOR = 1.83, 95% CI: 1.23-2.74) and an age range 45-54 years (AOR = 5.81, 95% CI: 2.30-14.69) to be significantly associated with reported COVID-19 knowledge. In addition, positive Attitude scores were associated with respondents living in Zimbabwe (AOR = 4.49, 95% CI: 2.04-9.90) and positive Practice scores were found to be associated with people from India (AOR = 3.68, 95% CI: 1.15-11.74) and high school education (AOR = 2.16, 95% CI: 1.07-4.38). This study contributes to the identification of socio-demographic factors associated with poor knowledge, attitudes, and practices relating to COVID-19 variants and vaccines. It presents an opportunity for collaboration with diverse communities to address COVID-19 misinformation and common sources of vaccine hesitancy (i.e., knowledge, attitudes, and practices).

Indexed as

COVID-19 vaccinationimmunization programspandemicsSARS-CoV-2 vaccine

Identifiers

PMID34821609
PMCPMC8614952
OpenAlexW3209223764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.